George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’. Watch the video here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksShield Thera Regulatory News (STX)

Share Price Information for Shield Thera (STX)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1.35
Bid: 1.30
Ask: 1.40
Change: 0.00 (0.00%)
Spread: 0.10 (7.692%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 1.35
STX Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Second Price Monitoring Extn

4 Aug 2021 16:41

RNS Number : 6116H
Shield Therapeutics PLC
04 August 2021
 

Second Price Monitoring Extension

A second and final Price Monitoring Extension has been activated in this security. The auction call period is extended in this security for a further 5 minutes.

Following the first price monitoring extension this security would still have executed more than a pre-determined percentage above or below the price of the most recent automated execution today. London Stock Exchange electronic order book users have a final opportunity to review the prices and sizes of orders entered in this security prior to the auction execution.

The applicable percentage is set by reference to a security's Millennium Exchange sector. This is set out in the Sector Breakdown tab of the Parameters document at www.londonstockexchange.com/tradingservices

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
APMDZGGRKDMGMZM

Date   Source Headline
30th Mar 20217:00 amRNSInvestor presentation
26th Mar 20217:00 amRNSStudy demonstrates effectiveness of ferric maltol
24th Mar 20215:40 pmRNSBlock Listing Application
23rd Mar 20215:53 pmRNSHolding(s) in Company
23rd Mar 202112:23 pmRNSHolding(s) in Company
22nd Mar 20217:00 amRNSShield appoints new Chief Financial Officer
18th Mar 20212:02 pmRNSResult of General Meeting & Open Offer
15th Mar 20215:21 pmRNSHolding(s) in Company
9th Mar 20217:00 amRNSAustralia's TGA approves Feraccru
5th Mar 20214:54 pmRNSPDMR Transaction Notification
4th Mar 20216:17 pmRNSPDMR/PCA Transaction Notification
3rd Mar 20211:40 pmRNSInvestor Presentation
1st Mar 20217:00 amRNSPublication of Circular and Notice of GM
26th Feb 20214:09 pmRNSSuccessful completion of £25 million Fundraise
26th Feb 202112:30 pmRNSTotal Voting Rights Update
26th Feb 202111:05 amRNSSecond Price Monitoring Extn
26th Feb 202111:00 amRNSPrice Monitoring Extension
26th Feb 20219:30 amRNSPlacing and Subscription to raise up to £25m
19th Feb 202111:05 amRNSSecond Price Monitoring Extn
19th Feb 202111:00 amRNSPrice Monitoring Extension
2nd Feb 20218:00 amEQSEdison Investment Research Limited: Shield Therapeutics (STX): Beefing up for the US opportunity
29th Jan 20212:38 pmRNSShareholder loan facilities
29th Jan 20217:00 amRNSTotal Voting Rights Update
21st Jan 20215:41 pmRNSDirector/PDMR Shareholding
19th Jan 20212:20 pmRNSDirector/PDMR Shareholding
15th Jan 202110:00 amRNSInvestor presentation
15th Jan 20217:00 amRNSBusiness and trading update
14th Jan 202111:05 amRNSSecond Price Monitoring Extn
14th Jan 202111:00 amRNSPrice Monitoring Extension
6th Jan 20217:15 amEQSHardman & Co Research: Shield Therapeutics (STX): Reassessing the US opportunity
31st Dec 20207:00 amRNSTotal Voting Rights Update
22nd Dec 202010:06 amRNSHolding(s) in Company
21st Dec 20207:00 amRNSInvestor Presentation
18th Dec 20205:21 pmRNSGrant of share options to the CEO
18th Dec 20205:15 pmRNSPDMR Exercise of Share Options
14th Dec 20207:00 amRNSDirector/PDMR Shareholding
14th Dec 20207:00 amRNSInvestor Presentation
10th Dec 202011:05 amRNSSecond Price Monitoring Extn
10th Dec 202011:00 amRNSPrice Monitoring Extension
10th Dec 20207:00 amRNSUpdate re US partnering discussions
30th Nov 20207:00 amRNSHolding(s) in Company
30th Nov 20207:00 amRNSTotal Voting Rights Update
2nd Nov 20207:00 amRNSTotal Voting Rights Update
19th Oct 20207:00 amRNSWithdrawal of all oppositions by TEVA
30th Sep 20201:21 pmRNSBlock Listing 6 Monthly Return
30th Sep 20201:20 pmRNSTotal Voting Rights Update
18th Sep 20201:30 pmEQSHardman & Co Research: Shield Therapeutics (STX): Optimism over US deal
16th Sep 20207:00 amRNSHalf-year Report
14th Sep 20207:00 amRNSNotice of Results
28th Aug 202012:21 pmRNSTotal Voting Rights Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.